News | July 10, 2013

Study Demonstrates Improved Monitoring of Patients at Risk for Cardiotoxicity Using EchoInsight for Cardio Oncology

Results indicate EchoInsight for Cardio Oncology is a high quality, efficient application for comprehensive assessment and serial comparison of left ventricle (LV) function

EchoInsight for Cardio Oncology Clinical Study Left Ventricle Function

July 10, 2013 — Epsilon Imaging Inc. announced a clinical study demonstrating EchoInsight for Cardio Oncology to be a high quality, efficient application for comprehensive assessment of left ventricle (LV) function. The study, presented at the ASE 2013 Scientific Sessions in Minneapolis, Minn., further indicated EchoInsight for Cardio Oncology facilitates monitoring of patients at risk for cardiotoxicity. EchoInsight for Cardio Oncology is a vendor neutral application designed to assist clinicians in improving confidence and workflow of study interpretation and reporting when monitoring oncology patients.

At ASE 2013, Jeanne DeCara, M.D., et al. from the University of Chicago Medicine presented, “Vendor Independent Software for Rapid Comprehensive Assessment of Changes in Left Ventricle Function During Serial Echocardiographic Studies.” The study analyzed serial comparison studies from 30 subjects. Ejection fraction (EF) and longitudinal strain were measured to monitor change in cardiac function. An experienced reader reviewed the studies on another commercially available solution, and an inexperienced reader used EchoInsight for Cardio Oncology for analysis. The inexperienced reader also completed analysis without EchoInsight for Cardio Oncology. Study results concluded that analysis and interpretation is faster using EchoInsight for Cardio Oncology when compared to the other commercial application, and offers consistent findings. EchoInsight for Cardio Oncology also slightly improved the inexperienced reader’s assessment of LV function change.

“Our study demonstrates EchoInsight for Cardio Oncology offers visualization and analysis that allows for quick, easy and accurate interpretation of LV function over time,” said DeCara. “EchoInsight is a promising software application that may assist in the follow-up of patients undergoing potentially cardiotoxic treatments, such as chemotherapy.”

For more information: www.epsilon-imaging.com

Related Content

AHRA and Canon Medical Systems Announce 2017 Putting Patients First Grant Winners
News | Patient Engagement | February 14, 2018
The Association for Medical Imaging Management (AHRA) and Canon Medical Systems recently announced the tenth annual...
Digisonics Customers Expand OB Ultrasound Reporting Systems for Improved Workflow Efficiency
News | Ultrasound Imaging | February 06, 2018
February 6, 2018 – Oregon Health and Science University in Portland, Ore., University of Utah Medical Center in Salt
Microbubbles Make Breast Cancer More Susceptible to Radiation Therapy
News | Women's Health | February 01, 2018
February 1, 2018 – Injecting breast cancer with oxygen-filled microbubbles makes tumors three-times more sensitive to
ASE Opens Enrollment for ImageGuideEcho Registry
News | Cardiovascular Ultrasound | January 29, 2018
January 29, 2018 — The American Society of Echocardiography (ASE) announced that ImageGuideEcho, a module under the I
Philips Introduces Technology Maximizer Program for Imaging Equipment Upgrades
Technology | Imaging | January 17, 2018
January 17, 2018 — Philips recently announced the launch of Technology Maximizer, a cross-modality program designed t
New Vascular Ultrasound Registry Looks to Enhance Patient Care
News | Cardiovascular Ultrasound | January 17, 2018
The Society for Vascular Ultrasound (SVU), the Society for Vascular Surgery (SVS) and Medstreaming-M2S announced the...
Sponsored Content | Videos | Ultrasound Imaging | January 11, 2018
Mindray recently featured a new upgrade for its premium Resona 7 ultrasound system at the Radiological Society of North...
Overlay Init